Search
Moroxydine
go.drugbank.com/drugs/DB13597ExperimentalCategories: Antivirals for Systemic Use, Antiinfectives for Systemic UseAZD-4017
go.drugbank.com/drugs/DB14875InvestigationalAZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).
NOP-1A
go.drugbank.com/drugs/DB15208InvestigationalNOP-1A is under investigation in clinical trial NCT01198197 (PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A).
AEM-28
go.drugbank.com/drugs/DB17642InvestigationalAEM-28 is a 28 amino acid mimetic of apolipoprotein E being investigated for lipid disorders, such as homozygous familial hypercholesterolemia. It possesses anti-inflammatory properties.[A258764]
Reloxiliase
go.drugbank.com/drugs/DB17653ExperimentalIt is being investigated for the treatment of hyperoxaluria.[A258823]
IMMU-114
go.drugbank.com/drugs/DB18458InvestigationalIMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.
ALT-P1
go.drugbank.com/drugs/DB18485InvestigationalIt is under investigation for the treatment of growth hormone deficiency.
RD13-02
go.drugbank.com/drugs/DB27110InvestigationalRD13-02 is under investigation in clinical trial NCT05923541 (RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies).
Fenthion
go.drugbank.com/drugs/DB11412ExperimentalVet approvedIts mode of action is explained by cholinesterase enzyme inhibition, which is similar to other organophosphates. … Fenthion is listed as a restricted use compound by the United States Environmental Protection Agency due to its potential to cause cholinesterase inhibition in humans and animals.
Categories: Compounds used in a research, industrial, or household settingNemonoxacin
go.drugbank.com/drugs/DB06600InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use